These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22469712)

  • 1. The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome.
    Spiliotis J; Efstathiou E; Halkia E; Vaxevanidou A; Datsis A; Sugarbaker P
    Hepatogastroenterology; 2012 May; 59(115):705-8. PubMed ID: 22469712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.
    Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
    Ann Surg Oncol; 2007 Feb; 14(2):493-9. PubMed ID: 17103067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
    Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
    Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
    Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pseudomyxoma peritonei.
    Fallis SA; Moran BJ
    J BUON; 2015 May; 20 Suppl 1():S47-55. PubMed ID: 26051332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications.
    Smeenk RM; Bex A; Verwaal VJ; Horenblas S; Zoetmulder FA
    J Surg Oncol; 2006 Jan; 93(1):20-3. PubMed ID: 16353186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
    Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
    In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion.
    De Simone M; Vaira M; Caponi A; Ciaccio B; Fiorentini G; Turrisi G; Ferri L; Buti G
    In Vivo; 2006; 20(6A):725-7. PubMed ID: 17203755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei: a review of 23 cases.
    Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
    Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei.
    Chua TC; Yan TD; Yap ZL; Horton MD; Fermanis GG; Morris DL
    J Surg Oncol; 2009 Apr; 99(5):292-5. PubMed ID: 19180588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.